Protein SLFN11 Sensitizes Pediatric Cancer Cell Lines to Chemotherapy Regimens
Researchers have demonstrated that SLFN11 expression markedly sensitizes pediatric cancer cell lines to cisplatin and talazoparib while showing context-dependent survival ...

